These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome. Morice E, Farley S, Poirier R, Dallerac G, Chagneau C, Pannetier S, Hanauer A, Davis S, Vaillend C, Laroche S. Neurobiol Dis; 2013 Oct; 58():156-68. PubMed ID: 23742761 [Abstract] [Full Text] [Related]
26. Hypothyroidism impairs late LTP in CA1 region but not in dentate gyrus of the intact rat hippocampus: MAPK involvement. Gerges NZ, Alkadhi KA. Hippocampus; 2004 Oct; 14(1):40-5. PubMed ID: 15058481 [Abstract] [Full Text] [Related]
30. Effects of physical exercise and stress on hippocampal CA1 and dentate gyrus synaptic transmission and long-term potentiation in adolescent and adult Wistar rats. Dahlin E, Andersson M, Thorén A, Hanse E, Seth H. Neuroscience; 2019 Jun 01; 408():22-30. PubMed ID: 30926550 [Abstract] [Full Text] [Related]
33. Simvastatin reverses the downregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats. Wang Q, Wang PH, McLachlan C, Wong PT. Brain Res; 2005 May 31; 1045(1-2):229-33. PubMed ID: 15910782 [Abstract] [Full Text] [Related]
35. MPTP modulates hippocampal synaptic transmission and activity-dependent synaptic plasticity via dopamine receptors. Zhu G, Huang Y, Chen Y, Zhuang Y, Behnisch T. J Neurochem; 2012 Aug 31; 122(3):582-93. PubMed ID: 22651101 [Abstract] [Full Text] [Related]
36. Blockade of intracellular Zn2+ signaling in the dentate gyrus erases recognition memory via impairment of maintained LTP. Tamano H, Minamino T, Fujii H, Takada S, Nakamura M, Ando M, Takeda A. Hippocampus; 2015 Aug 31; 25(8):952-62. PubMed ID: 25603776 [Abstract] [Full Text] [Related]
37. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Francardo V, Recchia A, Popovic N, Andersson D, Nissbrandt H, Cenci MA. Neurobiol Dis; 2011 Jun 31; 42(3):327-40. PubMed ID: 21310234 [Abstract] [Full Text] [Related]